Invention Grant
- Patent Title: Use of long-acting GLP-1 peptides
-
Application No.: US15656042Application Date: 2017-07-21
-
Publication No.: US10335462B2Publication Date: 2019-07-02
- Inventor: Christine Bjoern Jensen
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Leon Y. Lum
- Priority: EP12174535 20120701; EP12186781 20121001
- Main IPC: A61K38/26
- IPC: A61K38/26 ; A61P5/50 ; A61P3/04 ; A61P3/10
Abstract:
The invention relates to use of long-acting GLP-1 peptides in certain dosage regimes for the treatment of type 2 diabetes, obesity, etc.
Public/Granted literature
- US20180085435A1 Use of Long-Acting GLP-1 Peptides Public/Granted day:2018-03-29
Information query
IPC分类:
